Table 1.
Baseline demographics, clinics, pharmacotherapeutics and pharmaceutical care characteristics.
| Total cohort N=19 |
|
|---|---|
| Demographics | |
| Age (years) Mean ± SD | 69.4 ± 5.4 |
| Gender (Male) n (%) | 13 (68.4) |
| CDC classification (aids) | 6 (31.6) |
| Clinics | |
| CD4 level (> 200 cels/mL) | 17 (89.5) |
| Undetectable viral load (< 50 c/mL) | 18 (94.7) |
| Pharmacotherapeutics | |
| ART type* | |
| ITIAN + ITINN | 0 (0) |
| ITIAN + Inin | 9 (45.0) |
| ITIAN + IP | 4 (25.0) |
| Others** | 6 (30.0) |
| Concomitant medication. Mean ± SD | 6.8 ± 5.5 |
| Polymedicated n (%) | 16 (84.2) |
| MRCI*** (points). Mean ± SD | 11.9 ± 5.8 |
| Pharmaceutical care | |
| Beers Criteria. Median (IQR) | 1 (0-6) |
| STOPP Criteria. Median (IQR) | 1 (0-3) |
| Stratification ****a | |
| N3 | 12 (63.2) |
| N2 | 4 (20) |
| N1 | 3 (15.8) |
*
ART. Antiretroviral therapy; **Others include all ART regimens without ITIAN; ***MRCI denotes medication regimen complexity Index; ****Stratification according Spanish Society of Hospital Pharmacy.
a Distribution of MRCI according to stratification [N3, 9.8 ± 4.6; N2, 15.1 ± 4.1; N1, 19.6 ± 6.4; ANOVA Pintergroups <0.001]